Biotech Lock-Up Expiration Hell Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (936)	2/25/2004 12:08:24 AM
From: Jibacoa	Read Replies (1) of 1005

Re: INGN Will see if David Nance will be of some help to the stock tomorrow.It needs to close above 9 in order to try to break the present downtrend, and the general market is not helping.<g> BIO CEO & Investor Conference to Webcast Introgen Therapeutics Presentation AUSTIN, Texas, Feb. 24 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN) announced today that David G. Nance, president and chief executive officer of Introgen, will speak at the 6th Annual BIO CEO & Investor Conference in New York on Wednesday, February 25, at 3:30 p.m. EST. Mr. Nance is speaking during BIO CEO's focus session "Apoptosis and other novel- approaches to creating next generation cancer therapies." A live webcast of Mr. Nance's presentation may be accessed at firstcallevents.com . The focus session will be moderated by Dr. Roger Cohen of Fox-Chase Cancer Center and will include expert commentary by Dr. John Nemunaitis of US Oncology. Also participating in the session are senior management from Human Genome Sciences, Aegera, Antisoma and Allos Therapeutics.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next